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Cancer is the second largest non-communicable disease and it has a sizable contribution in the total 
number of deaths. Cancer of the urinary bladder ranks fourth in men and eighth in women with an 
alarming increase in cancer patients of this type every year. Tobacco smoking is considered to be one 
of the causes of bladder cancer and a number of organic chemicals used in the industry are known to 
be carcinogenic to the bladder. Chemical and dyestuff manufacturers are at particularly high risk of 
bladder cancer. Edible fungi are used as potential therapeutic agents for the treatment of cancers. This 
study was employed to find out the therapeutic potential of two medicinal mushroom varieties namely 
Pleurotus florida and Calocybe indica against T24 urinary bladder cancer cell lines. The therapeutic 
potential of the two medicinal mushroom varieties, P. florida and C. indica against T24 urinary bladder 
cancer cell lines were determined by the MTT assay and DNA fragmentation assay. The results obtained 
from the MTT assay and DNA fragmentation assay in this study showed the anti-tumour potential of 
these two mushroom varieties against T24 bladder cancer cell lines. Thus, the mushroom varieties P. 
florida and C. indica can be employed as potential anticancer drugs against bladder carcinoma. 
 





Cancer is a disease that occurs more frequently in later 
life and the proportion of cancers that occur in the elderly 
is increasing relative to younger age groups. By 2030, 
over 70% of all cancers are expected to occur in people 
aged over 65 years (Edwards et al., 2002). Proposed 
mechanisms for the increased incidence of cancer in the 
aging population include an accumulation of genetic and 
cellular damage, prolonged exposure to carcinogens and 
fundamental changes in the host environment. Cancer 
and aging are intimately linked at the most basic level: 
Convergent mechanisms protect against both aging and 
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pathways regulating cellular proliferation typically exert 
divergent or opposing effects; specifically, protecting from 
cancer but promoting aging (Serrano and Blasco, 2007).  
It certainly appears that the incidence of bladder cancer 
is increasing in India. Bladder cancer illustrates well the 
association between cancer and aging and occurs most 
commonly in the elderly: The median age at diagnosis is 
69 years for men and 71 years for women. Bladder 
cancer is also the fourth and eighth most common 
malignancy in men and women, respectively (American 
Cancer Society, 2009). According to the Delhi cancer 
registry, in 2003, bladder cancer was the sixth most 
common cancer, surpassed in frequency only by cancers 
of the lung, larynx, tongue, prostate and esophagus. 
Fifteen percent of all tobacco-related cancers are bladder 
cancers. Curiously, in Northern India, this disease seems 
to affect younger patients (Rawal, 2008). Bladder cancer,  




arising from the transitional cells of the mucosal 
urothelium, may present as a noninvasive, papillary 
tumour protruding from the mucosal surface, or as a 
solid, nonpapillary tumour that invades the bladder wall 
and has a high propensity for metastasis. The 
nonpapillary tumours originate from in situ dysplasia. 
Bladder cancer's staging, treatment and prognosis 
depend on how deeply it has invaded urinary bladder 
(Crawford, 2008). Fortunately, about 80% of patients with 
non-muscle invasive disease can be successfully treated 
using the surgery. Historically, two-thirds of patients have 
tumour recurrence within 5 years. High-grade tumours 
have a significantly worse prognosis. Both high-grade T1 
tumours and carcinoma in situ have the potential to 
progress and even metastasize (Dalbagni, 2007). 
Patients with invasive bladder cancer require a radical 
cystectomy. Controversy exists as to whether 
neoadjuvant or adjuvant chemotherapy improves survival 
in patients with invasive bladder cancer, despite a 
number of randomized controlled trials. So far, there are 
no data to confirm what is the best combination of 
treatments (neoadjuvant chemotherapy, adjuvant with or 
without radiotherapy) to treat invasive bladder cancer 
(Choueiri and Ragavan, 2008). The modest results with 
current drugs, suggest the urgent need to identify new 
agents from natural source to treat cancer. 
In this regard, edible fungi are frequently used as a 
therapeutic food having anti-carcinogenic, anti-
cholesterolaemic and anti-viral properties and also 
prophylactic properties with regard to coronary heart 
disease and hypertension (Bobek et al., 1995a, b; Mattila 
et al., 2000). Mushrooms also display certain medicinal 
properties and have a good biological efficiency (60 to 
70%) under optimum conditions. The moisture content of 
fresh mushrooms varies from 86 to 93% depending upon 
their environmental conditions and protein content varies 
from 2 to 3%. Due to its higher moisture content, they are 
highly perishable in nature and self life varies from 1 to 2 
days. Actually, world trade in mushrooms is as big as the 
trade in coffee. Mushroom polysaccharides support some 
or all of the major systems of the body, including nervous, 
hormonal and immune systems as well as regulatory 
functions. The polysaccharides from mushrooms do not 
attack cancer cells directly, but produce their antitumour 
effects by activating different immune response in the 
host (Wasser, 2002). 
The scientific community, in searching for new 
therapeutic alternatives, has studied many kinds of 
mushrooms and found variable therapeutic activites such 
as anticarcinogenic, anti-inflammatory, immune-
suppressor and antibiotic activity (Turkoglu et al., 2006). 
Although, the isolation process, structural 
characterization and antitumour activity of mushroom 
polysaccharides have been extensively investigated in 
the past three decades, the relationship between the 
antitumour activity and the chemical composition as well as 
the high order structure of their active components is still 





medicinal mushrooms occurring in south India namely 
Pleurotus florida and Calocybe indica possessed 
profound antioxidant, antibacterial and antitumour 
activities. In this regard, in 2007, Ajith and Janardhan 
investigated the anticancer properties of some Indian 
Mushrooms (Ajith and Janardhan, 2007). These studies 
are still in progress in many laboratories and the role of 
polysaccharides as antitumour agent is especially under 
intense debate (Zhang et al., 2006). The T24 cell line has 
been established from a highly malignant grade III human 
urinary bladder carcinoma (Bubenak et al., 1973). This 
cell line can be easily grown in vitro and has been 
extensively used to evaluate the therapeutic effects of 
several anticancer drugs. 
So, the current investigations will assist the 
confirmation of the utility of the bioactive compounds from 
the aforementioned said mushrooms namely P. florida 
and C. indica.  
 
 
MATERIALS AND METHODS 
 
Collection and preparation of sample 
 
Mushroom samples were collected from Blue hill mushroom 
producers and the sample was preserved in the Department of 
Biochemistry, by Dr N. G. P. Arts and Science College, Coimbatore. 
The mushrooms were shade dried and made into a coarse powder. 
The coarse powder was extracted using ethanol for 72 h in a 
Soxhlet’s apparatus. The ethanol was evaporated and the extract 
was concentrated and was used for the assay.   
 
 
Collection of cell T24 bladder transitional cell carcinoma cell 
lines 
 
Cell line T24 was provided by National Centre for Cell Sciences, 
Pune. Cells were grown as a monolayer in complete RPMI (RPMI-
1640 medium supplemented with 10% fetal calf serum, 100 U/ml 
penicillin and l00 U/ml streptomycin), in a humidified atmosphere 
with 7% CO2 93% air at 37°C. T24 cell lines were used as a bladder 




MTT assay   
 
The antitumor potential of the mushroom extracts were analysed by 
MTT assay (Mossmann, 1983), measurement of cell viability and 
proliferation forms the basis for numerous in vitro assays of a cell 
population’s response to external factors. The reduction of 
tetrazolium salts is now widely accepted as a reliable way to 
examine cell proliferation. The yellow tetrazolium MTT (3- (4, 5-
dimethylthiazolyl-2)-2,5- diphenyltetrazolium bromide) is reduced by 
metabolically active cells, in part by the action of dehydrogenase 
enzymes, to generate reducing equivalents such as NADH and 
NADPH. The resulting intracellular purple formazon can be 
solubilized and quantified by spectrophotometric means. 
 
 
DNA fragmentation assay 
 
The antitumor potential of the mushroom extracts were analysed by 
DNA fragmentation assay (Gong et al., 1994). DNA fragmentation 
assay provides a method  for  DNA  separation  of  fragmented  and  




Table 1. MTT Cytotoxicity assay of P. florida AND C. indica. 
 
S/N 
Concentration of extract 
(µg/ml) 
Percentage inhibition 
Pleurotus florida Calocybe indica 
1 10 39 ±2.36 34±1.46 
2 25 46±1.53 44±3.15 
3 50 60±1.82 57±2.63 
4 100 71±3.91 68±2.80 
LC 50 value 35.67 36.13 
 




intact DNA fractions and for their analysis by agarose gel 
electrophoresis. In apoptotic cells, specific DNA cleavage becomes 
evident in electrophoresis analysis as a typical ladder pattern due to 
multiple DNA fragments. This protocol is simple and generally able 






The study was carried out in triplicates. The statistics used was 






In this study, various concentrations of the ethanolic 
extract of P. florida and C. indica (10, 25, 50 and 
100 µg/ml) inhibited the growth of the urinary bladder 
carcinoma. Cell line T24 cell to a good extent and the 
percentage of inhibition brought about by the ethanolic 
extract of P. florida (39±2.36, 46±1.53, 60±1.82, 71±3.91) 
and C. indica (34±1.46, 44±3.15, 57±2.63, 68±2.80) are 
shown in Table 1; Figures 1 and 2. The percentage of 
inhibition increased in a dose dependent manner in both 
the extracts.  
 
 
DNA fragmentation assay 
 
The concentration of the ethanolic extract of P. florida (35 
µg/ml) and C. indica (36 µg/ml)  which showed 50% 
inhibition of  tumour cell line growth as obtained from the 
MTT assay is used for the DNA fragmentation assay. 
Fragmentation of genomic DNA to high molecular weight 
(180 to 200 kb) fragments is a characteristic of the early 
event in apoptosis and may represent the committed step 
of the process. Apoptosis or programmed cell death 
represents a physiological form of cell death that occurs 





Peng et al. (2005) reported that the T24 cells were found 
very susceptible to Antrodia camphorata extract which 
arrested the T24 cell growth at a concentration of 50 
µg/ml, assayed through MTT assay. The MTT assay is a 
rapid and sensitive spectrophotometric assay for 
determining viability in monolayer culture cell lines. The 
assay involves the conversion of the tetrazolium salt MTT 
by viable proliferating cells to an insoluble product, purple 
formazon. This study supported the present work. The 
result from this study revealed that the ethanolic extracts 
of P. florida and C. indica could arrest the growth of the 
cancer cell line T24. 
Cancer has a scourge on the human population for 
many years. Although, numerous advances have been 
made in prevention, diagnosis and treatment of the 
disease, it still continues to torment mankind (Hanahan 
and Weinberg, 2000).  
Chemoprevention (ingestion of chemical agents that 
reduce the risk of carcinogenesis) is one direct way to 
reduce this toll. Mushrooms that are useful against 
cancers of the stomach; esophagus, lungs, etc. are 
known in China, Russia, Japan and Korea, as well as in 
the United States and Canada. Approximately, 200 
species of mushrooms have been found to markedly 
inhibit tumour growth; although, most mushroom-origin 
antitumour substances have not been clearly identified. 
Polysaccharides from mushrooms do not attack cancer 
cells directly, but activate different immune responses in 
the host. Most of the active polysaccharides isolated from 
mushrooms can be classified as dietary fiber. β-Glucans 
and chitinous substances with carcinostatic activity, 
contained primarily in the dietary fiber of mushrooms, 
absorb hazardous materials.  
They prevent absorption and hastening excretion and 
may help prevent cancer of the colon and rectum. Lectins 
have been isolated and purified from several higher 
basidomycetes. These materials can be used for affinity 
chromatography, for diagnosis of cancer cells or as 
specific binding moieties for targeted cancer therapy 
(Wasser and Weis, 1999). With this background 
knowledge as supportive evidence, this study revealed 
the in vitro antitumour activity of the ethanolic extracts of 
P. florida and C. indica. 
Thus, from the MTT analysis carried out in the urinary 
bladder, tumour cell line T24 revealed the ethanolic 
extract of P. florida and C. indica could effectively reduce  
















the growth and multiplication of the tumour cell and 
ultimately suppress the growth of the tumour cells. The 
anticarcinogenic effect of the ethanolic extract of P. 
florida and C. indica may be due to the rich antioxidant 
content and the presence of secondary metabolites like 
flavonoids and phenols in them. Foods rich in antioxidants 






Figure 3. DNA fragmentation induced by the ethanolic extract of P. florida 
and C. indica. Lane 1, Marker DNA; lane 2 to 3, T24 cells + ethanolic extract 
of P. florida (35 µg/ml); lane 4 to 5, T24 cells + ethanolic extract of C. indica 




have been shown to play an essential role in the 
prevention of cardiovascular diseases, cancer, 
neurodegerative diseases, inflammation and problems 
caused by cell and cutaneous aging (Pratt, 1992). Most 
people if they think about mushrooms at all consider 
them a food with no particular value beyond taste. As a 
significant source of protein, fiber, several minerals, B 
vitamins and ascorbic acid, mushrooms are actually a 
healthy addition to the diet. They also have uses beyond 
nutrition, having numerous medicinal quantities (Meletis, 
2005). 
Agarose gel electrophoresis was used to evaluate 
whether high molecular DNA fragmentation was a feature 
of the cellular response of the tumour cell to the ethanolic 
extract of P. florida and C. indica. The internucleasomal 
DNA was detected on agarose gel as a ladder of DNA 
fragment (Figure 3) and this confirmed that the cytotoxic 
effect of the mushroom extracts is mediated via 
apoptosis. It is emphasized that, there was a close 
relationship between apoptosis and proliferation in 
malignant neoplasm cells. A characteristic DNA laddering 
was noticed only in tumor cell line treated with the 
ethanolic extract of P. florida and C. indica. This pattern 
was not observed in the control cells and the cells grown 
in ethanolic extract of P. florida and C. indica free 
medium. The data reported here demonstrated the lethal 
injury to carcinoma cells via activation of the cell death by  
both the ethanolic extract of P. florida and C. indica. 
Emerging research suggests that, mushrooms and 
mushroom extracts may have potent anticancer activity, 
for both breast and prostate cancer. Research shows 
that, 30 to 35% of all cancers can be prevented by eating 
well, being active and maintaining a healthy body weight 
(Canadian Cancer Society). As fresh mushrooms are low 
in calories and fat, as well as being versatile and great-
tasting, they are a good addition to a healthy eating 
pattern. They are satisfying as well, which may help keep 
the calories in check and weight at a healthy level. The 
Canadian cancer society recommends choosing 5 to10 
servings of vegetables and fruit every day to reap the 
benefits of their disease-fighting antioxidants and 
phytochemicals.  
Mushrooms offer nutrients such as β-glucans and 
conjugated linoleic acid, compounds that are currently 
being studied for their chemopreventive potential.  
Mushrooms are a valuable source of fiber, both insoluble 
(cellulose, lignin, chitin) and soluble the main constituents 
of which are β-glucans and chitosans (Sadler, 2003). 
Most clinical evidence for antitumour activities comes 
from the commercial polysaccharides isolated from 
shitake (Lentinus edodes) and maitake (Grifola frondosa) 
mushroom. The authors suggest that consuming 3.5 
ounces (100 g) of mushrooms per day would help 
suppress  breast   tumour   growth  in  women.  However,  




much more research, including human studies, needs to 
be done before any specific recommendations can be 
made. Numerous bioactive polysaccharides or 
polysaccharide-protein complexes from medicinal 
mushrooms are described that appear to enhance innate 
and cell-mediated immune responses and exhibit 
antitumour activities in animals and humans. Stimulation 
of the host immune defense systems by bioactive 
polymers from medicinal mushrooms has significant 
effects on the maturation, differentiation and proliferation 
of many kinds of immune cells in the host. Numerous 
reports have documented the ability of PSK and PSP to 
activate cellular and humoral components of the host 
immune system. In addition, these polysaccharides have 
been shown to inhibit the growth of tumour cell lines and 
to have in vivo anti-tumour activity (Tzianabos, 2000).  
The specificity of an anticancer compound against 
cancer cell depends on the proliferation rates of the 
treated cells. Cancer cells proliferate more rapidly than 
normal cells, which make them more sensitive to drug 
treatment. Plant-derived anticancer agents act by 
entering with cancer cell proliferation or by the induction 
of apoptosis in tumour cells (Ferreira et al., 2002). The 
advantage of apoptosis inducing anticancer drugs is that 
the apoptotic bodies formed can be scavenged by the 
human body’s immune system without inducing an 
inflammatory response (Frink and Cookson, 2005). In 
addition to apoptosis induction, another common effect 
shared by many anticancer drugs is the introduction of 
cell cycle arrest. Cell cycle arrest has been found in cells 
exposed to a variety of stimuli, including irradiation 
(Holgersson et al., 2005), microtubule stabilizing agents 
(Bhalla, 2003) and topoisomerase inhibitors (Tolis et al., 
1999; Potter and Rabinovitch, 2005).    
The anti-tumour activity of medicinal mushrooms has 
been evaluated in Japan for prevention of esophageal, 
gastric and lung cancers with promising results (Ng, 
1998). In   phase II and phase III trials in China, PSP 
significantly enhanced immune status in 70 to 97% of 
patients with cancer of the stomach, esophagus, lung 
ovary and cervix. In these studies, PSK and PSP 
increased the number of immune cells and facilitated 
dendritic and cytotoxic T-cell infiltration of tumours. The 
polysaccharides were well-tolerated and compatible with 
chemotherapy and radiation treatment. Based on the 
study, the ethanolic extract of P. florida and C. indica 





The result from the MTT assay showed that the ethanolic 
extracts of P. florida and C. indica at a concentration of 
35 and 36 µg/ml, respectively, could prevent the 
proliferation of the tumour cells. The DNA fragmentation 
assay also clearly indicates that the mushroom extracts 
could arrest the growth of tumour cell and could induce 
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